I've worked on a mAb and i will happily admit i didn't get the details! 1/
@PaoloWalnuts I looked into this as I was very surprised and thought it could be quite dangerous to go against the trial design.
I learnt a lot while i was doing it! There are a lot of misunderstandings and quite a few counterintuitive bits as well.
Thread...
I've worked on a mAb and i will happily admit i didn't get the details! 1/
I know how limited pfizer are in what they can claim. If they don't have data to prove something they can't claim it, even if it *really* is obvious. They have data on 21 days so they either stay quiet or they say the data support 21dy interval. 5/
So, why choose 21 days? 7/
21 days should long enough to work but quick enough to get data 9/
I'll try to hunt out the threads i came across. 10/
I also think it's been poorly communicated though. I understand why - in many ways JVCI, SAGE, MHRA et al have a lot to worry about right now! 12/
Clearly, in this case, giving everybody 1 dose will provide much more protecting and save very many lives.
*I'm coming on to this... 14/
15/
The numbers are skewed by all the pts who were infected before they were given the vx, or in the 7-14 days after it was administered. The fact that those folks get covid doesn't tell us how effective the vx is (just how long it takes to start working). So? 16/
We don't need to worry about the vaccine being effective after 1 dose. It is, stunningly so. 17/
https://t.co/5nw32LPiEk
What it suggests to me is that the projections for January and February must be properly frightening.
— Chris McQuillan (@ChrisMcQuilla13) January 1, 2021
https://t.co/WkD6pFZVbz
@Sandyddouglas
This issue is, appropriately, contentious. As a vaccinologist - & citizen & relative of people in at-risk groups - I fully support the UK decision to increase dose intervals of both our Ox/AZ product and the Pfizer product. I'd happily receive either with a >8w gap. Here's why \U0001f9f5 https://t.co/PZaxgGJUj4
— Sandy Douglas (@sandyddouglas) January 1, 2021
https://t.co/U3OEnGOrpw
Like me, \u2066@petermbenglish\u2069 changed his mind about the one v two vaccine dose controversy. He blogs why here. https://t.co/W8I5cm7LAk
— Trisha Greenhalgh \U0001f637 #RejoinEU (@trishgreenhalgh) January 2, 2021
More from Design
You May Also Like
make products.
"If only someone would tell me how I can get a startup to notice me."
Make Products.
"I guess it's impossible and I'll never break into the industry."
MAKE PRODUCTS.
Courtesy of @edbrisson's wonderful thread on breaking into comics – https://t.co/TgNblNSCBj – here is why the same applies to Product Management, too.
"I really want to break into comics"
— Ed Brisson (@edbrisson) December 4, 2018
make comics.
"If only someone would tell me how I can get an editor to notice me."
Make Comics.
"I guess it's impossible and I'll never break into the industry."
MAKE COMICS.
There is no better way of learning the craft of product, or proving your potential to employers, than just doing it.
You do not need anybody's permission. We don't have diplomas, nor doctorates. We can barely agree on a single standard of what a Product Manager is supposed to do.
But – there is at least one blindingly obvious industry consensus – a Product Manager makes Products.
And they don't need to be kept at the exact right temperature, given endless resource, or carefully protected in order to do this.
They find their own way.